Matteo Carrara
Overview
Explore the profile of Matteo Carrara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
867
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fuhrmann L, Jablonski K, Topolsky I, Batavia A, Borgsmuller N, Baykal P, et al.
Gigascience
. 2024 Sep;
13.
PMID: 39347649
The large amount and diversity of viral genomic datasets generated by next-generation sequencing technologies poses a set of challenges for computational data analysis workflows, including rigorous quality control, scaling to...
2.
Wegner F, Cabrera-Gil B, Tanguy A, Beckmann C, Beerenwinkel N, Bertelli C, et al.
Microbiol Spectr
. 2024 Mar;
12(5):e0362823.
PMID: 38497714
During the SARS-CoV-2 pandemic, many countries directed substantial resources toward genomic surveillance to detect and track viral variants. There is a debate over how much sequencing effort is necessary in...
3.
Lischetti U, Tastanova A, Singer F, Grob L, Carrara M, Cheng P, et al.
Commun Biol
. 2023 Aug;
6(1):830.
PMID: 37563418
Multi-omics profiling by CITE-seq bridges the RNA-protein gap in single-cell analysis but has been largely applied to liquid biopsies. Applying CITE-seq to clinically relevant solid biopsies to characterize healthy tissue...
4.
Grob L, Bertolini A, Carrara M, Lischetti U, Tastanova A, Beisel C, et al.
Bioinformatics
. 2023 May;
39(5).
PMID: 37220897
Summary: Recently, CITE-seq emerged as a multimodal single-cell technology capturing gene expression and surface protein information from the same single cells, which allows unprecedented insights into disease mechanisms and heterogeneity,...
5.
Renna L, Bertani F, Podio A, Boveri S, Carrara M, Pinton A, et al.
Vaccines (Basel)
. 2023 Feb;
11(2).
PMID: 36851340
Accurate studies on the dynamics of Pfizer-Biontech BNT162b2-induced antibodies are crucial to better tailor booster dose administration depending on age, comorbidities, and previous natural infection with SARS-CoV-2. To date, little...
6.
Voellenkle C, Fuschi P, Mutoli M, Carrara M, Righini P, Nano G, et al.
Cells
. 2022 Nov;
11(22).
PMID: 36428974
Redox imbalance of the endothelial cells (ECs) plays a causative role in a variety of cardiovascular diseases. In order to better understand the molecular mechanisms of the endothelial response to...
7.
Rossi G, Salvi E, Benussi L, Mehmeti E, Geviti A, Bellini S, et al.
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36361641
Genetic frontotemporal lobar degeneration (FTLD) is characterized by heterogeneous phenotypic expression, with a disease onset highly variable even in patients carrying the same mutation. Herein we investigated if variants in...
8.
Benussi L, Longobardi A, Kocoglu C, Carrara M, Bellini S, Ferrari C, et al.
Int J Mol Sci
. 2021 Dec;
22(24).
PMID: 34948429
Dysfunctions in the endo-lysosomal system have been hypothesized to underlie neurodegeneration in major neurocognitive disorders due to Alzheimer's disease (AD), Frontotemporal Lobar Degeneration (FTLD), and Lewy body disease (DLB). The...
9.
Malavazos A, Basilico S, Iacobellis G, Milani V, Cardani R, Boniardi F, et al.
Obesity (Silver Spring)
. 2021 Dec;
30(3):606-613.
PMID: 34850576
Objective: The excess of visceral adipose tissue might hinder and delay immune response. How people with abdominal obesity (AO) will respond to mRNA vaccines against SARS-CoV-2 is yet to be...
10.
Zaccagnini G, Greco S, Longo M, Maimone B, Voellenkle C, Fuschi P, et al.
Cell Death Dis
. 2021 May;
12(6):507.
PMID: 34006827
No abstract available.